Repurformer: Transformers for Repurposing-Aware Molecule Generation
Generating as diverse molecules as possible with desired properties is crucial for drug discovery research, which invokes many approaches based on deep generative models today. Despite recent advancements in these models, particularly in variational autoencoders (VAEs), generative adversarial networks (GANs), Transformers, and diffusion models, a significant challenge known as \textit{the sample bias problem} remains. This problem occurs when generated molecules targeting the same protein tend to be structurally similar, reducing the diversity of generation. To address this, we propose leveraging multi-hop relationships among proteins and compounds. Our model, Repurformer, integrates bi-directional pretraining with Fast Fourier Transform (FFT) and low-pass filtering (LPF) to capture complex interactions and generate diverse molecules. A series of experiments on BindingDB dataset confirm that Repurformer successfully creates substitutes for anchor compounds that resemble positive compounds, increasing diversity between the anchor and generated compounds.
Code (0)
등록된 구현이 없습니다.
Tasks
DiversityDrug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
NeuroCADR: Drug Repurposing to Reveal Novel Anti-Epileptic Drug Candidates Through an Integrated Computational Approach
Drug repurposing is an emerging approach for drug discovery involving the reassignment of existing drugs for novel purposes. An alternative to the traditional de novo process of drug development, repurposed drugs are fas…
Drug DiscoveryDrugGen 2: A disease-aware language model for enhancing drug discovery
Current computational approaches for drug design typically focus on generating molecules conditioned on specific targets or general molecular properties, often neglecting the influence of disease context on target behavi…
Reinforcement LearningDrug DiscoveryScaling Structure Aware Virtual Screening to Billions of Molecules with SPRINT
Virtual screening of small molecules against protein targets can accelerate drug discovery and development by predicting drug-target interactions (DTIs). However, structure-based methods like molecular docking are too sl…
Drug DiscoveryMolecular DockingHGTDR: Advancing Drug Repurposing with Heterogeneous Graph Transformers
Motivation: Drug repurposing is a viable solution for reducing the time and cost associated with drug development. However, thus far, the proposed drug repurposing approaches still need to meet expectations. Therefore, i…
Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Due to the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there is an urgent need for novel therapies and drugs. We conducted a large-scale virtual screening for small molecules that are p…
Drug Discovery